88 related articles for article (PubMed ID: 19230892)
1. Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy.
Yee MS; Pavitt DV; Richmond W; Cook HT; McLean AG; Valabhji J; Elkeles RS
Atherosclerosis; 2009 Aug; 205(2):528-32. PubMed ID: 19230892
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency.
Kuroda M; Holleboom AG; Stroes ES; Asada S; Aoyagi Y; Kamata K; Yamashita S; Ishibashi S; Saito Y; Bujo H
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1756-62. PubMed ID: 24876348
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.
Freeman LA; Shamburek RD; Sampson ML; Neufeld EB; Sato M; Karathanasis SK; Remaley AT
J Lipid Res; 2019 May; 60(5):1050-1057. PubMed ID: 30808683
[TBL] [Abstract][Full Text] [Related]
4. Familial lecithin-cholesterol acyltransferase deficiency: biochemical characteristics and molecular analysis of a new LCAT mutation in a Polish family.
Idzior-Waluś B; Sieradzki J; Kostner G; Małecki MT; Klupa T; Wesołowska T; Rostworowski W; Hartwich J; Waluś M; Kieć AD; Naruszewicz M
Atherosclerosis; 2006 Apr; 185(2):413-20. PubMed ID: 16051254
[TBL] [Abstract][Full Text] [Related]
5. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype.
Baass A; Wassef H; Tremblay M; Bernier L; Dufour R; Davignon J
Atherosclerosis; 2009 Dec; 207(2):452-7. PubMed ID: 19515369
[TBL] [Abstract][Full Text] [Related]
8. Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g).
Alrasadi K; Awan Z; Alwaili K; Ruel I; Hafiane A; Krimbou L; Genest J
Am J Cardiol; 2008 Nov; 102(10):1341-7. PubMed ID: 18993152
[TBL] [Abstract][Full Text] [Related]
9. A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy.
Zhu X; Herzenberg AM; Eskandarian M; Maguire GF; Scholey JW; Connelly PW; Ng DS
Am J Pathol; 2004 Oct; 165(4):1269-78. PubMed ID: 15466392
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F
Atherosclerosis; 2006 Oct; 188(2):455-61. PubMed ID: 16384561
[TBL] [Abstract][Full Text] [Related]
11. Lipid compositions of plasma major lipoproteins and lipoprotein lipase activity in hypolipidemic and hyperlipidemic siblings with familial LCAT deficiency.
Naito C; Teramoto T; Kato H; Watanabe T; Yamanaka T; Iwamoto A
Scand J Clin Lab Invest Suppl; 1978; 150():168-76. PubMed ID: 746345
[No Abstract] [Full Text] [Related]
12. LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.
Vaisman BL; Neufeld EB; Freeman LA; Gordon SM; Sampson ML; Pryor M; Hillman E; Axley MJ; Karathanasis SK; Remaley AT
J Pharmacol Exp Ther; 2019 Mar; 368(3):423-434. PubMed ID: 30563940
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B.
Lynn EG; Siow YL; Frohlich J; Cheung GT; O K
Kidney Int; 2001 Aug; 60(2):520-32. PubMed ID: 11473635
[TBL] [Abstract][Full Text] [Related]
14. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
[TBL] [Abstract][Full Text] [Related]
15. Biochemistry and clinical relevance of lipoprotein X.
Narayanan S
Ann Clin Lab Sci; 1984; 14(5):371-4. PubMed ID: 6476782
[TBL] [Abstract][Full Text] [Related]
16. Changes in the concentration of lipoprotein-X during incubation of postheparin plasma from patients with familial lecithin: cholesterol acyltransferase (LCAT) deficiency.
Ritland S; Stokke KT; Gjone E
Clin Chim Acta; 1976 Feb; 67(1):63-9. PubMed ID: 815065
[TBL] [Abstract][Full Text] [Related]
17. Effect of Nicotinic acid/Laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype.
Cenarro A; Puzo J; Ferrando J; Mateo-Gallego R; Bea AM; Calmarza P; Jarauta E; Civeira F
Metabolism; 2014 Mar; 63(3):365-71. PubMed ID: 24333007
[TBL] [Abstract][Full Text] [Related]
18. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
[TBL] [Abstract][Full Text] [Related]
19. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro.
Norum KR; Glomset JA; Nichols AV; Forte T; Albers JJ; King WC; Mitchell CD; Applegate KR; Gong EL; Cabana V
Scand J Clin Lab Invest Suppl; 1975; 142():31-55. PubMed ID: 169567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
